Skip to main content

Table 2 Laboratory data in patients with Kawasaki disease

From: Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease

 

Patient without CAL (n=238)

Patient with CAL (n=127)

p value

WBC × 10 3 /mm 3

13.07 ± 0.29

14.14 ± 0.48

p=0.183

Hemoglobin g/dl

11.26 ± 0.07

10.96 ± 0.12

p=0.029*

Platelets× 10 3 /mm 3

331.84 ± 7.29

343.88 ± 11.11

p=0.248

Monocyte(%)

6.24 ± 0.23

5.64 ± 0.24

p=0.359

Eosinophil(%)

3.17 ± 0.21

3.54 ± 0.34

p=0.631

Basophil(%)

0.72 ± 0.14

1.07 ± 0.20

p=0.061

AST U/L

67.95 ± 6.06

79.16 ± 10.23

p=0.40

ALT U/L

74.52 ± 7.06

92.93 ± 10.14

p=0.049*

CRP mg/L

79.31 ± 4.44

104.21 ± 7.29

p=0.006*

Albumin g/dL

3.80 ± 0.03

3.59 ± 0.06

p=0.005*

Sodium mEq/L

136.35 ± 0.27

135.27 ± 0.50

p=0.072

PLR

59.39 ± 4.61

47.37 ± 2.61

p=0.124

NLR

2.73 ± 0.15

3.95 ± 0.39

p=0.004*

Neutrophils× 103/mm3

7.79 ± 0.26

9.10 ± 0.40

p=0.019*

Lymphocytes× 10 3 /mm 3

3.79 ± 0.11

3.52 ± 0.18

p=0.069

  1. Data are expressed as mean ± standard errors. ALT Alanine aminotransferase, AST Aspartate aminotransferase, CAL Coronary artery lesions, CRP C-reactive protein, NLR Neutrophil/lymphocyte ratio, PLR Platelet/ lymphocyte ratio, WBC White blood cells; *p < 0.05.